BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 19166794)

  • 21. [LADA--latent autoimmune diabetes in adults].
    Szelachowska M
    Endokrynol Pol; 2007; 58(3):246-51. PubMed ID: 17940991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Latent autoimmune diabetes in adults (LADA) should be less latent.
    Fourlanos S; Dotta F; Greenbaum CJ; Palmer JP; Rolandsson O; Colman PG; Harrison LC
    Diabetologia; 2005 Nov; 48(11):2206-12. PubMed ID: 16193284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diabetes mellitus--differential diagnosis].
    Hummel M; Füchtenbusch M
    MMW Fortschr Med; 2006 May; 148(20):47-50. PubMed ID: 16805191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of C-peptide levels in screening for latent autoimmune diabetes in adults.
    Bell DS; Ovalle F
    Am J Ther; 2004; 11(4):308-11. PubMed ID: 15266224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden.
    Thunander M; Petersson C; Jonzon K; Fornander J; Ossiansson B; Torn C; Edvardsson S; Landin-Olsson M
    Diabetes Res Clin Pract; 2008 Nov; 82(2):247-55. PubMed ID: 18804305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinguishing type 1 and type 2 diabetes at diagnosis. What is the problem?
    Rosenbloom AL
    Pediatr Diabetes; 2007 Apr; 8(2):51-2. PubMed ID: 17448126
    [No Abstract]   [Full Text] [Related]  

  • 27. The utility of the C-peptide in the phenotyping of patients candidates for pancreas transplantation.
    Esmatjes E; Fernández C; Rueda S; Nicolau J; Chiganer G; Ricart MJ; Junca E; Fernández-Cruz L
    Clin Transplant; 2007; 21(3):358-62. PubMed ID: 17488385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adults.
    Brophy S; Yderstraede K; Mauricio D; Hunter S; Hawa M; Pozzilli P; Schernthaner G; Schloot N; Buzzetti R; Davies H; Leslie D; Williams R;
    Diabetes Care; 2008 Mar; 31(3):439-41. PubMed ID: 18083788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum adiponectin as a useful marker for metabolic syndrome in type 2 diabetic patients.
    Yun JE; Sull JW; Lee HY; Park E; Kim S; Jo J; Lee SJ; Kim SY; Choi YJ; Jee SH; Huh KB
    Diabetes Metab Res Rev; 2009 Mar; 25(3):259-65. PubMed ID: 19214966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Latent autoimmune diabetes in Tunisian adults (LADA): identification of autoimmune markers.
    Amrouche Ch; Jamoussi Kamoun H; Trabelsi N; Blouza Chabchoub S
    Tunis Med; 2008 Apr; 86(4):316-8. PubMed ID: 19476130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Obesity in children and adolescents and diabetes].
    Nazim J; Starzyk J
    Przegl Lek; 2009; 66(1-2):96-9. PubMed ID: 19485265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of microvascular complications in metabolic syndrome in comparison to type 2 diabetes mellitus.
    Ahamed A; Shantha GP; Agarwal G; Senthil N; Paunikar N; Sudhakar MK
    J Indian Med Assoc; 2008 Sep; 106(9):583-4, 586, 588. PubMed ID: 19552085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunomodulation for the prevention of SPIDDM and LADA.
    Pozzilli P; Guglielmi C
    Ann N Y Acad Sci; 2006 Oct; 1079():90-8. PubMed ID: 17130536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Significance of the determination of C-peptide in type 2 diabetes].
    Perusicová J; Skachová J
    Vnitr Lek; 1987 Feb; 33(2):134-9. PubMed ID: 3548038
    [No Abstract]   [Full Text] [Related]  

  • 35. Latent autoimmune diabetes of adults (LADA).
    Ola TO; Gigante A; Leslie RD
    Nutr Metab Cardiovasc Dis; 2006 Apr; 16(3):163-7. PubMed ID: 16580583
    [No Abstract]   [Full Text] [Related]  

  • 36. [Insulin dependent (type 1) diabetes mellitus in advanced age].
    Halmos T; Suba I; Kautzky L
    Orv Hetil; 1998 Nov; 139(47):2829-31. PubMed ID: 9846062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Type 1 and type 2 diabetes mellitus in Germany. An epidemic in all age groups].
    Danne T
    MMW Fortschr Med; 2004 May; 146(20):27. PubMed ID: 15344728
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prevalence of GAD antibodies in Korean women with gestational diabetes mellitus and their clinical characteristics during and after pregnancy.
    Yu SH; Park S; Kim HS; Park SY; Yim CH; Han KO; Yoon HK; Jang HC; Chung HY; Kim SH
    Diabetes Metab Res Rev; 2009 May; 25(4):329-34. PubMed ID: 19405080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and risk factors for diabetic retinopathy at diagnosis (DRAD) in patients recently diagnosed with type 2 diabetes (T2D) or latent autoimmune diabetes in the adult (LADA).
    Martinell M; Dorkhan M; Stålhammar J; Storm P; Groop L; Gustavsson C
    J Diabetes Complications; 2016; 30(8):1456-1461. PubMed ID: 27593902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.